RBR-9bb2pt尚未招募未知
Evaluation of subjective dermatological clinical efficacy and safety with healthcare product appreciability_TCI
Ipclin - Pesquisa Clínica Integrada0 个研究点开始时间: 2018年4月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 65Y（—）
入选标准
- •Age between 18 to 65 years; Female or male; Phototypes I to IV; Subjects susceptible to the appearance of wound and/or contact dermatitis; Able to follow the guidelines and reliable to respect the restrictions of the protocol.
排除标准
- •Skin marks in the experimental area that interfere with the evaluation of possible skin reactions (pigmentation disorders, vascular malformations, scars, increased hairiness, ephelides and nevus in large quantities, sunburn); Active dermatoses (local and disseminated) that may interfere with the results of the study; Pregnant or lactating women; History of allergic reactions, irritation or intense feelings of discomfort to topical products: cosmetics and medicines; Participants with a history of allergy to the material used in the study; History of atopy; History of conditions aggravated or triggered by ultraviolet radiation; Immunodeficiency carriers; Renal, cardiac or hepatic transplanted; Intense sun exposure or tanning session up to 15 days prior to initial assessment; Prediction of intense sun exposure or the tanning session during the period of study conduction; Forecast to take a bath, pool or sauna during the study; Participants who practice water sports; Use of the following topical systemic medications: immunosuppressants, antihistamines, non-hormonal anti-inflammatories, and corticosteroids up to two weeks prior to selection; Treatment with acid vitamin A and / or its derivatives orally or topically up to 01 month before the start of the study; Prediction of vaccination during the study or until 03 weeks before the study; Be participating in another study; Any condition not mentioned above that, in the opinion of the investigator, could compromise the evaluation of the study; History of absence of adherence or unwillingness to adhere to the study protocol; Professionals directly involved in the accomplishment of this protocol and their relatives.
研究者
相似试验
已完成
不适用
Study to evaluate the dermatological skin condition of babies (T01)Healthy babyJPRN-UMIN000032375Kao Corporation160
已完成
不适用
Evaluation of dermatological safety and adverse reaction of Tactivin Immunoplus (Immunomodulator) cream, Tactivin Anti Wrinkle cream and Tomicid (Antibacterial peptide) cream along with their Placebo with a 48 hours closed patch skin sensitization test on 24 healthy adult volunteersCTRI/2011/11/002112Remedia Therapeutics Pvt Ltd24
招募中
不适用
Safety testing of cosmetic product using Patch TestCTRI/2021/07/035262Entice Supplements Pvt Ltd
已完成
不适用
To understand the safety of investigational products by assessing the irritation after patch application on human volunteers.CTRI/2012/06/002724ITC RD Centre24
已完成
不适用
Safety testing of cosmetic products by patch testCTRI/2017/05/008582ITC Limited ITC Life Sciences Technology Centre35